An antibody that prevents the hemagglutinin low pH fusogenic transition
about
Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivoA highly conserved neutralizing epitope on group 2 influenza A virusesStructural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesAntibody recognition of a highly conserved influenza virus epitopeDynamic Viral Glycoprotein Machines: Approaches for Probing Transient States That Drive Membrane FusionBrief History and Characterization of Enhanced Respiratory Syncytial Virus DiseaseStructural characterization of viral epitopes recognized by broadly cross-reactive antibodiesMechanisms of hemagglutinin targeted influenza virus neutralizationpH-Induced Conformational Change of the Rotavirus VP4 Spike: Implications for Cell Entry and Antibody NeutralizationCrystal structure of unliganded influenza B virus hemagglutinin.Structural Characterization of an Early Fusion Intermediate of Influenza Virus HemagglutininA neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutininsBroadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutininCross-neutralization of influenza A viruses mediated by a single antibody loopHeterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidityInfluenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 VirusesHuman antibodies that neutralize respiratory droplet transmissible H5N1 influenza virusesA Unique and Conserved Neutralization Epitope in H5N1 Influenza Viruses Identified by an Antibody against the A/Goose/Guangdong/1/96 HemagglutininReceptor mimicry by antibody F045–092 facilitates universal binding to the H3 subtype of influenza virusConserved Neutralizing Epitope at Globular Head of Hemagglutinin in H3N2 Influenza VirusesAnti-Hemagglutinin Antibody Derived Lead Peptides for Inhibitors of Influenza Virus BindingLarge-scale analysis of B-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies.In silico structural homology modelling and docking for assessment of pandemic potential of a novel H7N9 influenza virus and its ability to be neutralized by existing anti-hemagglutinin antibodies.Intermonomer Interactions in Hemagglutinin Subunits HA1 and HA2 Affecting Hemagglutinin Stability and Influenza Virus InfectivityThe Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin.In silico characterization of the functional and structural modules of the hemagglutinin protein from the swine-origin influenza virus A (H1N1)-2009.Structural basis of influenza virus neutralization.Passive immune neutralization strategies for prevention and control of influenza A infections.Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model.Mapping antibody epitopes of the avian H5N1 influenza virusEvolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin.Changed epitopes drive the antigenic drift for influenza A (H3N2) viruses.Transient humoral protection against H5N1 challenge after seasonal influenza vaccination of humansStructural changes in Influenza virus at low pH characterized by cryo-electron tomographyLack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus diseaseInfluenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion.Serologic screenings for H7N9 from three sources among high-risk groups in the early stage of H7N9 circulation in Guangdong Province, China.A comprehensive map of the influenza A virus replication cycleStructural basis for Marburg virus neutralization by a cross-reactive human antibody.Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.
P2860
Q24568302-DACC5EFD-A640-4E5F-ABFC-D290C5FA4B5CQ24630467-D84A1518-E246-4AAD-9A9B-9AFBD1789C37Q24649949-34B39FD5-FDFA-4010-912E-3D1432604413Q24655932-078A8985-66CF-43EA-9570-CF52D57ECAA0Q26772129-E21BF54A-E2A0-4989-A816-04565582F86CQ26775152-9B914520-4929-40F1-A965-88FA2D808DBBQ26823492-8C4FA9F7-E770-4DA3-8FD0-09F1680C7F35Q27302234-27361A27-5318-4367-B1B9-1259CE89BBE5Q27469845-D1762FE7-9F6A-4F1F-A95E-8EB180573D81Q27649507-391F4C9C-2A0B-4208-A97B-8111F448DF0EQ27667137-9BC426C0-A3AC-4355-A29D-74E06927D7A3Q27671165-443DE2C9-DD50-4254-9F54-C57ED7FD9C27Q27671619-A8D7F443-5FE6-4C19-A97C-F3ACBEBE0BABQ27673206-B3E50CBA-FDCE-476E-8CE6-D95106239FFFQ27673861-F2586DE9-CA02-4389-824A-886574EAC213Q27675477-944DBE4F-A3D9-4C52-BC5F-70F064F95C8AQ27679859-8EC71CC4-6449-4570-8A3B-467AC8BCA5C4Q27679987-D24133B6-E96A-4C83-AD53-360C70F5B05CQ27683156-4C659C8E-1C2B-4B5B-94A3-1F7F6E3E2AF1Q27683198-C7939057-418D-4917-B8B7-C5FDD2F5F414Q28552622-C2AA866B-F643-4A5C-AE9C-0D43F0257CFAQ30217235-FC6243F3-AC10-4A2E-8452-B344F5086031Q30364943-D2803E22-549B-4169-9EE8-D54E22F6B11AQ30377845-E9B6AF8D-BAF1-4C82-97FC-C91B11B89D31Q30387177-104FEF28-9EC7-448A-933A-D5DE00DD46C2Q30391096-1EF90BD1-6E67-441A-AD74-99D5954BBDFEQ30398754-650E8D03-E936-4875-B14D-1340E63E9453Q30413158-C69B83B9-3767-4C70-BAB9-93D305CF675CQ30430458-FA00BF51-ADBE-49DE-B90E-0AA66901D0B5Q33432749-BCE38D61-28D1-4D41-9ADC-27C936DADC8DQ33520040-39BAF72C-3F24-4CFA-9370-D87E8CA01AFAQ33826981-2662BDEB-0DE0-434E-8D74-3B1492D2A1CCQ33975449-D2BE962D-CF0E-4832-9026-4DFD94DA1911Q34132726-B9F02651-4E69-4B48-8D75-6927514C8237Q34330690-EFE29C72-CEE4-4908-A811-6CAAE6C58883Q34360974-C76A4EE4-C789-4B60-8690-DC3E43B3C857Q34812637-A2EC5D88-4D6A-4B84-BC23-C88FF3419BF0Q35006697-D3A995FF-E0CB-4A4F-AA3B-D49A230F5822Q35132751-126B7872-610E-4D8A-B1E6-DE8DDD096863Q35139986-82A55EF5-ACC1-46C4-86A2-6955F944189A
P2860
An antibody that prevents the hemagglutinin low pH fusogenic transition
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
An antibody that prevents the hemagglutinin low pH fusogenic transition
@ast
An antibody that prevents the hemagglutinin low pH fusogenic transition
@en
An antibody that prevents the hemagglutinin low pH fusogenic transition
@nl
type
label
An antibody that prevents the hemagglutinin low pH fusogenic transition
@ast
An antibody that prevents the hemagglutinin low pH fusogenic transition
@en
An antibody that prevents the hemagglutinin low pH fusogenic transition
@nl
prefLabel
An antibody that prevents the hemagglutinin low pH fusogenic transition
@ast
An antibody that prevents the hemagglutinin low pH fusogenic transition
@en
An antibody that prevents the hemagglutinin low pH fusogenic transition
@nl
P2093
P3181
P356
P1433
P1476
An antibody that prevents the hemagglutinin low pH fusogenic transition
@en
P2093
Barbey-Martin C
Bizebard T
Wharton SA
P3181
P356
10.1006/VIRO.2001.1320
P407
P577
2002-03-01T00:00:00Z